['dry eye disease']
['cyclasol topical ocular, eye drops', 'vehicle topical ocular, eye drops']

        Inclusion Criteria:

          -  Signed ICF (Informed Consent Form) and HIPAA (Health Insurance Portability and
             Accountability Act)

          -  Patient-reported history of DED in both eyes

          -  Current use of OTC (over-the-counter) and/or artificial tears for dry eye symptoms

          -  Ability and willingness to follow instructions, including participation in all study
             assessments and visits

        Exclusion Criteria:

          -  Women who are pregnant, nursing or planning a pregnancy

          -  Unwillingness to submit a urine pregnancy test at screening and the last visit (or
             early termination visit) if of childbearing potential, or unwillingness to use
             acceptable means of birth control

          -  Clinically significant slit-lamp findings or abnormal lid anatomy at screening

          -  Ocular/periocular malignancy

          -  History of herpetic keratitis

          -  Active ocular allergies or ocular allergies that may become active during the study
             period

          -  Ongoing ocular or systemic infection at screening or baseline

          -  Wear of contact lenses within 3 months prior to screening or anticipated use of
             contact lenses during the study

          -  History of no response to previous topical Cyclosporine A and/or use of topical
             Cyclosporine A or Liftigrast within 2 months prior to screening

          -  Intraocular surgery or ocular laser surgery within the previous 6 months, or have any
             planned ocular and/or lid surgeries over the study period

          -  Presence of uncontrolled systemic diseases

          -  Presence of known allergy and/or sensitivity to the study drug or its components
      